随着减重药巨头诺和诺德重磅GLP-1类药物司美格鲁肽在中国的核心分子专利即将于3月到期，一大批中国本土的司美格鲁肽仿制药正在获批路上。据公开信息，目前国内市场上包括九源基因、丽珠集团、华东医药、齐鲁制药、正大天晴在内的十多家本土制药公司的司美格鲁肽仿制药有望在不久的将来上市，还有十余款处于三期临床，一场价格大战即将席卷。一位内分泌专家表示，随着更多仿制药的上市，减重药很快就会迎来“白菜价”时代。（第一财经）
Дональд Трамп. Фото: Jen Golbeck / Keystone Press Agency / Global Look Press。业内人士推荐WPS下载最新地址作为进阶阅读
，详情可参考搜狗输入法2026
Customers had to pay a deposit for the sturdy glass bottles. They then got this money back when they returned them to the shop. And the bottles would be washed and refilled over and over again.，更多细节参见搜狗输入法下载
Many scientists agree that it would be the best or perhaps only way to provide continuous power on the lunar surface.
- 父节点i的左子: 2*i+1, 右子: 2*i+2